Bio-Rad Laboratories logo

BIO

NYSE

Bio-Rad Laboratories

Price unavailable — configure POLYGON_API_KEY

Key Statisticslimited data
Market Cap$7.55B
P/E RatioN/A
Div. Yield
EPS (TTM)-$21.82
52W High
52W Low
SectorHealth Care
Industry
Employees7,450
Price Performance
1 Week+5.50%
3 Month-13.14%
1 Year+19.27%
FinancialsAnnual · QuiverQuant
Revenue$2.67B
Assets$12.30B
Liabilities$3.56B
Net Income$637.32M loss

About

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Company Info

HERCULES, CA
7,450 employees
Listed 1980-02-29
laboratory analytical instruments
📞(510) 724-7000
WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze BIO with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.